TherapeuticsMD, Inc. (TXMD)

NasdaqGS • Currently down 0.05 (-2.70%) in today's trading session

1 member of Congress has disclosed 6 trades in TherapeuticsMD, Inc. (TXMD) via STOCK Act filings. The most recent disclosure was a sale by James Comer on 12 December 2017. Aggregate disclosed activity totals roughly $40K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

TherapeuticsMD, Inc. is currently trading at $1.80, positioned at 37% of its 52-week range ($1.11 – $2.95).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$1.80
24h Change
-0.05 (-2.70%)
52 Week Range
$1.11–$2.95
View on NASDAQ

TherapeuticsMD, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for TXMD

Select to highlight on chart
5 transactions
Compliance: 0%
James Comer12 Dec 201715 May 2018SaleStock$1,001 - $15,000N/A
James Comer15 Sept 201715 May 2018PurchaseStock$1,001 - $15,000N/A
James Comer5 Dec 20168 May 2017PurchaseStock$1,001 - $15,000N/A
James Comer5 Dec 201617 Jul 2017PurchaseStock$1,001 - $15,000N/A
James Comer29 Nov 201617 Jul 2017PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$20.83M

Volume

15.7K

Beta

0.65

P/E Ratio

91.70

Fundamentals

EPS

$0.02

Div. Yield

-

Open

$1.87

Day Range

$1.76 – $1.87

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ · USD
Country
US
CEO
Marlan D. Walker
IPO Date
2007-05-09
Website
www.therapeuticsmd.com

TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradi...

Earnings

Next Report

Q3 2026

17 Nov

EPS Est.

$-6.13

Rev. Est.

$19.8M

Days Until

23

Recent Quarters

Q2 202611 Aug
EPS$0.01
Beat 100.2%
Q1 202612 May
EPS$0.01
Beat 100.2%
Q4 202530 Mar
EPS$-0.05
Miss 233.8%
Q3 202512 Nov
EPS$0.01
Q2 202512 Aug
EPS$0.05
Q1 202513 May
EPS$-0.06
Q4 202427 Mar
EPS$0.02
Miss 45.4%
Q3 202412 Nov
EPS$-0.05
Miss 225.0%
Q2 202412 Aug
EPS$-0.09
Miss 400.0%
Q1 202410 May
EPS$-0.07
Miss 333.3%
Q4 202329 Mar
EPS$-0.08
Beat 38.5%
Q3 202314 Nov
EPS$-0.13
Beat 13.3%
Q2 202314 Aug
EPS$-0.24
Miss 242.9%
Q1 202315 May
EPS$-0.24
Miss 500.0%
Q4 202227 Mar
EPS$-3.55
Miss 219.6%
Q3 202214 Nov
EPS$-3.13
Miss 53.4%
Q2 202215 Aug
EPS$12.39
Beat 507.6%
Q1 202216 May
EPS$-4.72
Miss 34.9%
Q4 202110 Mar
EPS$-4.50
Miss 50.0%
Q3 202111 Nov
EPS$-5.50
Miss 10.0%
Q2 20214 Aug
EPS$-5.50
Beat 0.0%
Q1 20216 May
EPS$-5.50
Miss 10.0%
Q4 20202 Mar
EPS$-7.50
Miss 50.0%
Q3 20209 Nov
EPS$-5.00
Beat 28.6%
Q2 20206 Aug
EPS$-8.50
Miss 13.3%
Q1 20206 May
EPS$-10.50
Miss 10.5%
Q4 201920 Feb
EPS$-9.50
Beat 5.0%
Q3 20196 Nov
EPS$-6.50
Beat 31.6%
Q2 20196 Aug
EPS$-9.50
Miss 5.6%
Q1 20196 May
EPS$-8.00
Beat 5.9%
Q4 201821 Feb
EPS$-8.50
Beat 0.0%
Q3 20187 Nov
EPS$-8.00
Beat 27.3%
Q2 201830 Jul
EPS$-7.50
Miss 25.0%
Q1 20183 May
EPS$-5.50
Miss 10.0%
Q4 201720 Feb
EPS$-5.00
Miss 11.1%
Q3 20176 Nov
EPS$-3.50
Beat 22.2%
Q2 20173 Aug
EPS$-5.00
Beat 0.0%
Q1 20172 May
EPS$-5.50
Beat 0.0%
Q4 201623 Feb
EPS$-6.00
Beat 0.0%
Q3 20163 Nov
EPS$-6.50
Miss 18.2%
Q2 20164 Aug
EPS$-5.50
Miss 10.0%
Q1 20163 May
EPS$-5.50
Miss 10.0%
Q4 201525 Feb
EPS$-5.00
Beat 0.0%
Q3 20154 Nov
EPS$-5.50
Beat 15.4%
Q2 20156 Aug
EPS$-8.00
Miss 33.3%
Q1 20155 May
EPS$-6.50
Miss 30.0%
Q4 201410 Mar
EPS$-5.00
Miss 11.1%
Q3 20146 Nov
EPS$-6.00
Miss 71.4%
Q2 20146 Aug
EPS$-3.50
Beat 12.5%
Q1 20145 May
EPS$-3.00
Beat 0.0%
Q4 20133 Mar
EPS$-3.00
Beat 0.0%
Q3 20134 Nov
EPS$-3.00
Miss 50.0%
Q2 20136 Aug
EPS$-2.50
Beat 16.7%
Q1 201310 May
EPS$-3.09
Q1 20138 May
EPS$-3.00
Miss 9.1%
Q3 201213 Nov
EPS$-2.22
Q2 20129 Aug
EPS$-6.88
Q1 201211 May
EPS$-7.86
Q4 201127 Mar
EPS$-0.16
Q3 20117 Nov
EPS$-6.72
Q2 201115 Aug
EPS$-4.97
Q1 201119 May
EPS$55.06
Q1 201115 Apr
EPS$-0.66
Q3 20105 Nov
EPS$9.48
Q2 20103 Aug
EPS$-84.67
Q1 201026 Apr
EPS$-110.00
Q4 200917 Mar
EPS$-4.00
Q3 200916 Nov
EPS$-210.75
Q2 200910 Jul
EPS$-23.23
Q1 200929 Apr
EPS$-47.60
Q4 200818 Mar
EPS$-0.36
Q3 200829 Oct
EPS$-76.24
Q2 20088 Aug
EPS$-499.12
Q1 200813 May
EPS$-105.42
Q1 20081 May
EPS$-2.70
Q3 200713 Nov
EPS$281.62
Q1 200730 Jun
EPS$199.84
Q1 200715 May
EPS$164.76
Q4 200627 Mar
EPS$4.94
Q3 20069 Nov
EPS$467.13
Q2 200614 Aug
EPS$237.32
Q1 200612 May
EPS$175.17
Q4 200528 Mar
EPS$5.60
Q3 200514 Nov
EPS$328.71
Q2 200513 Aug
EPS$27.51
Q1 200517 May
EPS$223.98
Q4 20041 Mar
EPS$4.95
Q3 200412 Nov
EPS$161.12
Q2 200413 Aug
EPS$81.39
Q1 200414 May
EPS$-72.55
Q4 200325 Mar
EPS$1.68
Q3 200314 Nov
EPS$124.56
Q2 200314 Aug
EPS$36.42
Q1 200314 May
EPS$32.60
Q4 200231 Mar
EPS$2.12
Q3 200214 Nov
EPS$69.07
Q2 200214 Aug
EPS$49.04
Q1 200214 May
EPS$67.31
Q4 200129 Mar
EPS$-1.32
Q3 200114 Nov
EPS$40.06
Q2 200115 Aug
EPS$101.71
Q1 200117 May
EPS$124.74
Q4 200030 Mar
EPS$4.37
Q3 200014 Nov
EPS$116.67
Q2 200014 Aug
EPS$48.65
Q1 200015 May
EPS$34.70
Q4 199931 Mar
EPS$-0.09
Q3 199916 Nov
EPS$38.31
Q2 19996 Aug
EPS$30.45
Q1 199914 May
EPS$-24.05

No dividend data available for this stock.

Stock Splits

Split History

9 May 2022Reverse Split
Ratio1:50
3 Oct 2011Reverse Split
Ratio1:100
27 Jul 2009Stock Split
Ratio3:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

MDT

Medtronic plc

47
$95.41-1.18 (-1.22%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

AAPL

Apple Inc.

17
$347.73-0.50 (-0.14%)
Technology
Held by same politician
1 politician
View Stock

PLTR

Palantir Technologies Inc.

17
$196.75+0.56 (+0.29%)
Technology
Held by same politician
1 politician
View Stock

Frequently Asked Questions about TXMD

Which members of Congress have traded TXMD?
1 member of Congress has disclosed 6 trade in TherapeuticsMD, Inc. (TXMD) under the STOCK Act: James Comer.
When was TXMD most recently disclosed by Congress?
The most recent TXMD disclosure was a sale by James Comer on 12 December 2017.
What is the total disclosed congressional trading volume for TXMD?
Members of Congress have disclosed approximately $40K in TXMD purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in TXMD?
This TXMD page updates as soon as new STOCK Act disclosures are filed for TherapeuticsMD, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.